Ironwood Pharmaceuticals, Inc. (IRWD)
No Active SignalKey Metrics
Current Price
$3.52
Intrinsic Value
$18.31
Margin of Safety
80.8%
ROIC
33.2%
Debt / Equity
—
Sector
Healthcare
AI Analysis
Moat Assessment
The company's focus on pharmaceuticals and significant R&D expenses may provide
Red Flags
Negative stockholders' equity and significant long-term debt are major red flags
Management Signals
The company's ability to generate operating income despite net losses suggests m
Signal History
| Date | Price | MoS % | Conviction | Signal |
|---|---|---|---|---|
| 2026-06-18 | $3.52 | 80.8% | 6.0 | DEEP VALUE - WATCH (80.8% MoS, 6/10 conviction) |
| 2026-06-09 | $3.29 | 82.0% | 6.0 | DEEP VALUE - WATCH (82.0% MoS, 6/10 conviction) |
| 2026-06-07 | $3.31 | 44.9% | 6.0 | STRONG VALUE - WATCH (44.9% MoS, 6/10 conviction) |
| 2026-04-14 | $3.65 | 77.1% | 6.0 | DEEP VALUE - WATCH (77.1% MoS, 6/10 conviction) |
Related — Healthcare
Get alerts for IRWD
Receive signal changes and deep value alerts for Ironwood Pharmaceuticals, Inc..